Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income (loss)	$ 512,977	$ (3,005,109)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization expense	2,065,502	2,290,130
Amortization of operating lease right-of-use assets	570,369	570,369
Share-based compensation	154,898	150,712
Increase (decrease) in non-cash contingent consideration	83,578	(442,321)
Increase in cash surrender value of life insurance policies over premiums paid	(40,507)	(101,538)
Noncash interest expense	10,723	8,654
Accounts receivable	1,384,555	(1,861,587)
Inventories, net	1,818,196	1,243,245
Other current assets and other assets	640,023	424,684
Operating lease liabilities	(440,442)	(429,064)
Accounts payable and other current liabilities	(2,018,925)	(1,925,886)
Other long-term liabilities	1,371	85,404
Net cash provided by (used in) operating activities	4,742,318	(2,992,307)
Cash flows from investing activities:
Additions to property and equipment	74,116	48,799
Net investment in manufacturing	836,095	0
Additions to intangible assets	32,111	56,191
Net cash used in investing activities	(942,322)	(104,990)
Cash flows from financing activities:
Proceeds from ATM offering, net	5,266,334	0
Borrowings on line of credit	0	22,000,000
Payments on line of credit	(10,035,437)	(18,692,552)
Cash settlement of contingent consideration	(654,757)	(813,478)
Payments made in connection with repurchase of common shares	(253,039)	(381,851)
Net cash (used in) provided by financing activities	(5,676,899)	2,112,119
Net decrease in cash and cash equivalents	(1,876,903)	(985,178)
Cash and cash equivalents at beginning of period	17,964,184	18,321,624
Cash and cash equivalents at end of period	$ 16,087,281	$ 17,336,446